From Stacie Dusetzina at Health Affairs <[email protected]>
Subject Dear David...
Date August 14, 2025 2:01 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
Join Our Prior Authorization Event

View in browser ([link removed] )

LinkedIn ([link removed] )

YouTube ([link removed] )

Facebook ([link removed] )

X ([link removed] )

Instagram ([link removed] )

Website ([link removed] )

Dear John,

This is a preview of Insider's Prescription Policy Newsletter. Join Insider to read the whole essay ([link removed] ) .

Join Health Affairs on September 23 for an exclusive Insider virtual event exploring prior authotization policies and their impact with Mark Fendrick, Michael Anne Kyle, Ravi Gupta, and Christina Andrews.

Join Us
([link removed] )

Dear David...

In late July, President Trump sent the heads of 17 of the US’s best known drug makers letters asking them to lower the prices of their drugs.

In a widely shared photo ([link removed] ) , the White House press secretary holds up an example that was sent to the head of Eli Lilly, David Ricks, striking out the formal greeting and using just, “Dear David.”

This personalization hints at a friendlier relationship than the text of the letter might otherwise convey.

This letter (and presumably the others that were sent) goes on to list a series of requests to be completed by the companies in the next 60 days.

According to the letter’s text and a fact sheet ([link removed] ) published, the administration expects companies to:

- Provide all of their drugs at most favored nations rates for all Medicaid enrollees,
- Guarantee the most favored nation rate for new drugs for all US payers, including in Medicare, Medicaid, and commercial plans, and
- Provide the same price to patients paying cash through direct distribution models.

So, just provide those lower prices as requested in 60 days? Oh boy. What is an executive to do with this bit of information?

To Read the Whole Essay, Purchase Health Affairs Insider

Join Insider
([link removed] )

LinkedIn ([link removed] )

YouTube ([link removed] )

Facebook ([link removed] )

X ([link removed] )

Instagram ([link removed] )

Website ([link removed] )

About Health Affairs

Health Affairs is the leading peer-reviewed journal ([link removed] ) at the intersection of health, health care, and policy. Published monthly by Project HOPE, the journal is available in print and online.

Sign up for all of our newsletters ([link removed] ) , including Health Affairs Today and Health Affairs Sunday Update.

Project HOPE ([link removed] ) is a global health and humanitarian organization that places power in the hands of local health care workers to save lives across the globe. Project HOPE has published Health Affairs since 1981.

Copyright © Project HOPE: The People-to-People Health Foundation, Inc.

Privacy Policy ([link removed] )

Health Affairs, 1220 19th St. NW, Suite 800, Washington,DC,20036,United States,202-408-6801

Unsubscribe ([link removed] ) Manage Preferences ([link removed] )
Screenshot of the email generated on import

Message Analysis

  • Sender: n/a
  • Political Party: n/a
  • Country: n/a
  • State/Locality: n/a
  • Office: n/a